The Ex Ante Incentive Compatible Core in the Absence of Wealth Effects

In a differential information economy with quasi–linear utilities, monetary transfers facilitate the fulfillment of incentive compatibility constraints: the associated ex ante core is generically nonempty. However, we exhibit a well–behaved exchange economy in which this core is empty, even if goods are allocated through random mechanisms.     

Guidelines for Use of the Approximate Beta‐Poisson Dose–Response Model

For dose–response analysis in quantitative microbial risk assessment (QMRA), the exact beta‐Poisson model is a two‐parameter mechanistic dose–response model with parameters and , which involves the Kummer confluent hypergeometric function. Evaluation of a hypergeometric function is a computational challenge. Denoting as the probability of infection at a given mean dose d, the widely used dose–response model is an approximate formula for the exact beta‐Poisson model. Notwithstanding the required conditions and , issues related to the validity and approximation accuracy of this approximate formula have remained largely ignored in practice, partly because these conditions are too general to provide clear guidance. Consequently, this study proposes a probability measure Pr(0 < r < 1 | , ) as a validity measure (r is a random variable that follows a gamma distribution; and are the maximum likelihood estimates of α and β in the approximate model); and the constraint conditions for as a rule of thumb to ensure an accurate approximation (e.g., Pr(0 < r < 1 | , ) >0.99) . This validity measure and rule of thumb were validated by application to all the completed beta‐Poisson models (related to 85 data sets) from the QMRA community portal (QMRA Wiki). The results showed that the higher the probability Pr(0 < r < 1 | , ), the better the approximation. The results further showed that, among the total 85 models examined, 68 models were identified as valid approximate model applications, which all had a near perfect match to the corresponding exact beta‐Poisson model dose–response curve.